-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$10.00415.46% Upside
Can-Fite BioPharma Ltd. Frequently Asked Questions
-
What analysts cover Can-Fite BioPharma Ltd.?
Can-Fite BioPharma Ltd. has been rated by research analysts at EF Hutton in the past 90 days.